CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 60 enrolled
Drug / intervention
Triptan +1 moredrug
Likely dose
Treximet 85Mg-500Mg Tabletfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01086358
NCT01086358Phase 4Completed
CompareCT.gov

A Single Center Randomized Open-Label Two Arm Crossover Study of Subject Productivity Improvement and Satisfaction With Migraine Treatment Using Treximet vs Usual Triptan

The Cleveland Clinic·interventional·Posted Mar 15, 2010·Updated May 1, 2018

In Brief

A Phase 4 clinical trial evaluating Triptan and Treximet 85Mg-500Mg Tablet for Workplace Migraine Treatment. Completed, enrolled 60 participants across 1 site.

Detailed Summary

Researchers want to learn about work productivity after treatment of a migraine headache with your usual migraine medication as compared to your work productivity after treatment with Treximet. During this research subjects will take Treximet to treat 3 workday migraine attacks. For a second part of the research subjects will take their usual prescribed medication for 3 workday migraine attacks. The subjects will complete questionnaires after treating each migraine.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsWorkplace Migraine Treatment
CountriesUnited States
CollaboratorsGlaxoSmithKline, Currax Pharmaceuticals

Timeline

Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 15, 2010
Enrollment StartSep 1, 2009
Primary CompletionAug 1, 2016
TodayJul 2, 2026
Enrollment to primary: 6.9 yearsPosted 16.3 years ago

Interventions

Triptandrug

Usual prescribed triptans may include:sumatriptan, rizatriptan, naratriptan, almotriptan, eletriptan, zolmitriptan

Treximet 85Mg-500Mg Tabletdrug

Treximet is 85 mg sumatriptan plus 500 mg naproxen sodium